These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7738208)

  • 1. Drugs and endogenous ligands compete for receptor occupancy.
    Colburn WA
    J Clin Pharmacol; 1994 Dec; 34(12):1148-52. PubMed ID: 7738208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatum.
    Członkowski A; Höllt V; Herz A
    Life Sci; 1978 Mar; 22(11):953-62. PubMed ID: 205747
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of competitive ligand binding results in QSAR studies.
    Gómez-Jeria JS
    Farmaco Sci; 1985 May; 40(5):299-302. PubMed ID: 4007152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of receptor interactions using binding methods.
    Lazareno S
    J Recept Signal Transduct Res; 2001; 21(2-3):139-65. PubMed ID: 11757681
    [No Abstract]   [Full Text] [Related]  

  • 6. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
    Pfeiffer A; Herz A
    Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.
    Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA
    Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current views on endogenous ligands for opiate recognition sites.
    Cox BM
    Clin Neuropharmacol; 1986; 9 Suppl 4():211-3. PubMed ID: 2882839
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new group of hormones, endogenous ligands for drug receptors].
    Schreiber V
    Cesk Fysiol; 1986; 35(3):219-23. PubMed ID: 2941169
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug design by the method of receptor fit.
    Goodford PJ
    J Med Chem; 1984 May; 27(5):558-64. PubMed ID: 6716396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Receptors; from idea to reality].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1983 Jul; 127(28):1235-8. PubMed ID: 6310420
    [No Abstract]   [Full Text] [Related]  

  • 13. pA2 and receptor differentiation: a statistical analysis of competitive antagonism.
    Tallarida RJ; Cowan A; Adler MW
    Life Sci; 1979 Aug; 25(8):637-54. PubMed ID: 388133
    [No Abstract]   [Full Text] [Related]  

  • 14. Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor.
    Schiller PW; Lipton A; Horrobin DF; Bodanszky M
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1332-8. PubMed ID: 217386
    [No Abstract]   [Full Text] [Related]  

  • 15. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    MacKay D
    J Pharm Pharmacol; 1978 May; 30(5):312-3. PubMed ID: 26747
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).
    Robson LE; Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1979 Aug; 205(1160):425-32. PubMed ID: 41257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The ways of designing new-generation medicinal and biochemical agents by using ligand-receptor interactions for active membrane transport].
    Iurkevich AM; Shvets VI
    Vestn Ross Akad Med Nauk; 1999; (3):3-7. PubMed ID: 10222823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The classification of drugs and drug receptors in isolated tissues.
    Kenakin TP
    Pharmacol Rev; 1984 Sep; 36(3):165-222. PubMed ID: 6093156
    [No Abstract]   [Full Text] [Related]  

  • 19. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.
    Kimura T; Ohta T; Watanabe K; Yoshimura H; Yamamoto I
    Biol Pharm Bull; 1998 Mar; 21(3):224-6. PubMed ID: 9556149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental procedure for estimating the dissociation constant of noncompetitive interactants. Part I.
    Orsetti M
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):51-7. PubMed ID: 3718726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.